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Dendrobium species, commonly known as “Shihu” or “Huangcao,” represents the second largest genus of Orchidaceae, which are
used commonly as tonic herbs and healthy food in many Asian countries. The aim of this paper is to review the history, chemistry,
and pharmacology of differentDendrobium species on the basis of the latest academic literatures found in Google Scholar, PubMed,
Sciencedirect, Scopus, and SID.
1. Introduction
The origin of orchids (Orchidaceae) probably has to be
backdated to 120 million years ago. It is the largest family
group among angiosperms, as well as themost highly evolved
family of the flowering plants, with approximately 25,000 to
35,000 species under 750 to 900 genera [1–4]. Dendrobium
species, commonly known as “Shihu” or “Huangcao,” is
the second largest genus in Orchidaceae. Most Dendrobium
species grow best in relatively high and mountainous areas,
at 1400–1600m above sea level, at a mild temperature, and
in a humid and foggy environment. Characterized by a
broad geographical distribution, which allows Dendrobium
species to grow into tremendous diversities producing a large
number of interspecific hybrids with different morphological
features, they are widely distributed in Asia, Australia, and
Europe, for instance, in India, Sri Lanka, China, Japan,
Korea, New Guinea, and New Caledonia [5]. In the early
age, using molecular approaches would delimit the subtribe-
Dendrobiinae, affecting approximately 1100 species (900 in
Dendrobium Sw.) from Indo-Asian and Pacific regions [6, 7],
and more than 1200 species in Australasia are from various
Dendrobium species. Today, Indo-Asian and Pacific regions
have one of the largest and most diverse and taxonomically
problematic orchid groups [8]. Interestingly, there has been
a long history of the usage of first-rate herbs and folk
traditional herbs in India and China [9].
Since the ancient times (600 B.C.) in India, the oldest
references regarding the use of medicinal herbs are found
in the Sanskrit literature, namely, “Charaka Samhita.” The
earliest treatise on “Ayurveda” describes the property of plant
drugs and their uses. In the Ayurvedic system of medicine,
Flickingeria macraei is used in “Ayurveda.” It is commonly
named as “jeevanti” and is used as an astringent to the
bowels, as an aphrodisiac, and in asthma and bronchitis
[10]. Other commonly used orchid drugs in the Ayurvedic
system are salem, including jewanti (Dendrobium alpestre).
Similarly, it is the first time for China to regard orchids as
herbal medicines [11]. The Emperor “Shen-Nung” advised on
the medicinal properties of Dendrobium species in “materia
medica” in the 28th century B.C. [12]. As early as 200 B.C., the
Chinese pharmacopoeia “The Sang Nung Pen Tsao Ching”
mentioned Dendrobium as a source of tonic, astringent,
analgesic, and anti-inflammatory substances [13]. In Song
Dynasty (960–1279 A.D.). It mentioned the medicinal uses of
orchids, namely Dendrobium species according A Diagnosis
of Medical Herbs from the “Zheng Lei Ben Cao”. In Ming
Dynasty (1368–1644) many references on the use of orchids
as medicinal herbs were available [14].
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2. The Chemical Compounds of
Dendrobium Species
The stem of Dendrobium species has been used in traditional
Chinesemedicine as a tonic and antipyretic since ancient days
for treating human disorders. However, misidentification
and adulteration led to a loss of therapeutic potency and
potential intoxication. For decades, fast developingmolecular
techniques using DNA fingerprinting, DNA sequencing, and
DNA microarray have been applied extensively to authen-
ticate Chinese medicinal materials, including various Den-
drobium species [15], namely, D. aphyllum, D. candidum, D.
chrysanthum, D. densiflorum, D. huoshanense, D. gratiosissi-
mum,D. longicornu,D. nobile,D. secundum,D. chrysotoxum,
D. crystallinum, D. fimbriatum, and others [16]. In the early
years, Williams and Harborne conducted a major survey
of leaf flavonoids at the Plant Science Laboratories of the
University of Reading in UK. They conducted research on
142 species belonging to 75 genera and found that the most
common constituents were flavone C-glycoside and flavonols
[17]. Since then, about 100 compounds from 42 Dendrobium
species including 32 alkaloids, 6 coumarins, 15 bibenzyls, 4
fluorenones, 22 phenanthrenes, and 7 sesquiterpenoids con-
stituents have been discussed and reviewed [18–31] (Table 1).
To date, various Dendrobium species are known to produce
a variety of secondary metabolites. The biological activities
and pharmacological actions of all of these compounds were
investigated in detail [32–39].
3. The Pharmacological Effects of
Dendrobium Species
3.1. Antioxidant Activities. Oxidative stress is induced by
free radicals that participate in a variety of chemical reac-
tions with biomolecules, leading to a pathological condition.
Reactive oxygen species (ROS) is one of the major free
radicals. It mainly comprises superoxide (O
2
−) and nitric
oxide (NO) radicals, including (1) catalase (CAT), (2) perox-
idase (POD), (3) ascorbate peroxidase (APX), (4) 2,2󸀠-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) or ABTS, (5)
hydroxyl, and (6) 1,1-diphenyl-2-picrylhydrazyl (DPPH) rad-
icals. During these processes, it was found that the content of
malondialdehyde (MDA) was increased.
However, cells possess two distinctive antioxidant defense
systems to counteract the damage, including enzymatic anti-
oxidants and nonenzymatic antioxidants. Enzymatic antiox-
idants comprise catalase, superoxide dismutase (SOD), gluta-
thione peroxidase (GPx), and others associated with en-
zymes/molecules. Nonenzymatic antioxidants include ascor-
bic acid (vitamin C), 𝛼-tocopherol (vitamin E), and 𝛽-
carotene, which play a key role in removing reactive oxygen
species.
Oxidative stresses have been classified as exogenous
factors and endogenous factors. Factors related to environ-
mental stress includewater/soil drought stress, chilling injury
stress, and soundwave stress.Therewere studies on the effects
of cold storage on cut Dendrobium inflorescences, showing
that chilling injury symptoms for floral buds and open flowers
ofDendrobium could lead to oxidative stress, stemming from
the production of reactive oxygen species. In this process, the
decrease of cellular functions by peroxidation of membrane
lipids when lipoxygenase enzymes are degraded in cells.
However, this physiological process in floral buds and open
flowers is part of antioxidant defense systems, which can
decrease the content of oxygen free radicals and other oxygen
compounds. It indicates the protective cellular functions and
antioxidant capacity. This is an adaptive nature to ensure
some plants survive in the freezing winter [62].
In addition, soundwave stress is one of the environmental
stresses, similar to the low temperature stress. Studies of
the effects of sound wave stress on D. candidum yielded
data indicated it as a lipid peroxidation parameter which
can regulate the levels of MDA. Firstly, the MDA content in
different organs is increased and then declines afterwards,
which will then be followed by an increase again. That gives
a net increase of the level of MDA. It was noted that the
MDA level appears to be the lowest when the activities of
antioxidant enzymes are the highest. However, the levels
of MDA are yet to be fully understood. We believe the
antioxidant enzymes could protect plant cells from oxidative
damage in sound wave stress [63]. However, the correlation
between themechanisms of antioxidant action and the sound
wave stress and chilling injury stress has yet to be identified.
Water deficit caused by soil drought is one of the most
frequent environmental stresses. The effects of exogenous
drought menace, prompting further increases in the activity
of ROS and decrease in themalondialdehyde (MDA) content,
to prevent the breakage of DNA and protein degradation
from doing damage to plant life [64]. It is well known
that nitric oxide (NO) is a ubiquitous signal molecule
involved in many life processes of plants, seed germination,
hypocotyl elongation, leaf, expansion, root growth, lateral
roots initiation, and apoptosis, and so forth. It is also involved
in multiple plant responses to environmental stress. Data
demonstrated that, at lower concentrations of exogenous NO
with 50mmol L−1 SNP, the activation of POD, SOD, and CAT
was significantly increased, and the MDA content decreased
with 50Ml SNP.NO could protect D. huoshanense against the
oxidative insult caused by a drought stress; meanwhile, a high
level of RWCcan bemaintained. Furthermore, it suggests that
the molecular messenger NO can trigger epigenetic variation
and increase the demethylation ratio ofmethylated sites forD.
huoshanense by using DNA analysis. These results may imply
that the expression of some genes is involved in the response
to drought stress triggered by NO [65].
Numerous Dendrobium species such as D. nobile, D. den-
neanum, D. huoshanense, D. chrysotoxum, D. moniliforme, D.
tosaense, D. linawianum, D. candidum, D. loddigesii, and D.
fimbriatum have polysaccharides as the active compounds.
Polysaccharides play important roles in many biological
processes and are used to treat various diseases [66, 67].
Polysaccharides isolated from D. nobile, D. huoshanense, D.
chrysotoxum, andD. fimbriatum species manifest antioxidant
and free radical scavenging activities. D. nobile polysac-
charide displayed the highest scavenging activity toward
hydroxyl, ABTS, and DPPH free radicals [40, 68, 69]. How-
ever,D. fimbriatum polysaccharide has significant scavenging
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Table 2: Polysaccharides DDP1-1, DDP2-1, and DDP3-1 isolated
from D. denneanum and DNP1-1 DNP2-1, DNP3-1, and DNP4-2
isolated from D. nobile.
ABTS
radicals
Hydroxyl
radicals
DPPH
radicals
D. denneanum
DDP1-1 (LW) (LW) (LW)
DDP2-1 (LW) (HH) (HH)
DDP3-1 (LW) (LW) (LW)
D. nobile
DNP1-1 (LW) (LW) (LW)
DNP2-1 (LW) (LW) (LW)
DNP3-1 (LW) (LW) (LW)
DNP4-2 (HH) (HH) (HH)
∗Notes: Low (LW); High (HH).
Up the table: the antioxidant effect ofDNP4-2 onABTS, hydroxyl, andDPPH
free radicals, suggesting the levels of DNP4-2 higher than DNP1-1, DNP2-1,
and DNP3-1; however, the antioxidant effects of DDP2-1 on hydroxyl and
DPPH free radicals were higher than ABTS free radicals. Moreover, the
DDP1-1 and DDP 3-1 on inhibitory effect were low than other compounds.
We believe that the focus on antioxidant potential of DNP4-2 and DDP2-1
structures in near future.
action toward ABTS free radicals, and it also shows a weak
DPPH free radical scavenging action. On the contrary, D.
denneanum polysaccharide exerts a powerful DPPH free
radical scavenging action, but its ABTS scavenging effect
is not obvious [54]. In addition, both D. huoshanense and
D. chrysotoxum polysaccharides reveal an insufficient ABTS
free radical scavenging effect. However, it manifests poten-
tial hydroxyl radical scavenging activity. Overall, the free
radical scavenging activities of polysaccharides on hydroxyl
and DPPH free radicals remain at a high level, but the
inhibitory effect on ABTS free radicals is weak. The above
results, compared with other types of polysaccharides from
D. denneanum andD. nobile, are shown in Tables 2 and 3, and
others are shown in Table 4 [41, 53]. The polysaccharide ofD.
huoshanensehas a backbone of (1→ 4)-linked𝛼-D-Glcp, (1→
6)-linked 𝛼-D-Glcp, and (1→ 4)-linked 𝛽-D-Manp from
mannose (Man), glucose (Glc), and a trace of galactose (Gal).
Its antioxidant effect in the livers of CCl4-treated mice was
evidenced by a decrease of malondialdehyde (MDA) and
increase of superoxide dismutase (SOD), catalase (CAT), and
glutathione peroxidase (GPx) [70].
3.1.1. The Antioxidant Activities of Bibenzyl Derivatives, Phe-
nanthrenes, and Stilbenes from D. candidum and D. loddi-
gesii. Four new bibenzyl derivatives, dendrocandin F, den-
drocandin G, dendrocandin H, and dendrocandin I, are
extracted from D. candidum. They act as antioxidant agents
to clear up the free radicals. Accordingly, the IC50 values
of dendrocandin F and dendrocandin G are 55.8mM and
32.4mM, respectively [49]. A series of structurally related
compounds from D. loddigesii, known as loddigesiinol A–
D, suppress the production of nitric oxide (NO) with IC
50
values of 2.6mM for loddigesiinol A, 10.9mM for loddi-
gesiinol B, and 69.7mM for loddigesiinol D. Further study
Table 3: Assessment of the ABTS, hydroxyl, and DPPH scavenging
abilities of DNP and compounds DNP4-2, DNP2-1, DNP3-1, and
DNP1-1 derived from DNP.
DNP, DNP4-2, DNP2-1, DNP3-1, and DNP1-1
0.5mg for DPPH
scavenging (%)
1mg for DPPH
scavenging (%)
Type Scavenging (%) Type Scavenging (%)
DNP 20 DNP 20–30
DNP4-2 20–30 DNP4-2 30–40
DNP2-1 5–10 DNP2-1 10–20
DNP3-1 About 5 DNP3-1 <5
DNP1-1 <5 DNP1-1 About 5
0.5mg for ABTS
scavenging (%)
1mg for ABTS
scavenging (%)
Type Scavenging (%) Type Scavenging (%)
DNP 30–40 DNP <60
DNP4-2 About 40 DNP4-2 >60
DNP2-1 <20 DNP2-1 About 40
DNP3-1 ≥20 DNP3-1 30–40
DNP1-1 10 DNP1-1 30
0.5mg for hydroxyl
scavenging (%)
1mg for hydroxyl
scavenging (%)
Type Scavenging (%) Type Scavenging (%)
DNP 30–40 DNP 35–40
DNP4-2 20–30 DNP4-2 30–35
DNP2-1 10 DNP2-1 10–15
DNP3-1 5–10 DNP3-1 10
DNP1-1 0 DNP1-1 5
Based on data for DNP, DNP4-2, DNP2-1, DNP3-1, and DNP1-1
scavenging (%)
DPPH scavenging % (0.5mg content): DNP4-2 > DNP > DNP2-1
> DNP3-1 > DNP1-1
DPPH scavenging % (1mg content): DNP4-2 > DNP > DNP2-1 >
DNP1-1 > DNP3-1
ABTS scavenging % (0.5mg content): DNP4-2 > DNP > DNP3-1
> DNP2-1 > DNP1-1
ABTS scavenging % (1mg content): DNP4-2 > DNP > DNP2-1 >
DNP3-1 > DNP1-1
Hydroyl scavenging % (0.5mg content): DNP > DNP4-2 >
DNP2-1 > DNP3-1 > DNP1-1
Hydroyl scavenging % (1mg content): DNP > DNP4-2 > DNP2-1
> DNP3-1 > DNP1-1
Up the table: it is shown that DPPH and ABTS free radical scavenging (%) of
DNP4-2 are better than other compounds; however, the hydroxyl free radical
scavenging (%) of DNP is better than other compounds.
indicated that phenanthrenes and dihydrophenanthrenesin
D. loddigesii have significant effects on inhibiting the pro-
duction of NO and DPPH free radicals. These compounds
are known as (numbered as 1a–7a) phenanthrenes (1a),
phenanthrenes (2a), phenanthrenes (3a), phenanthrenes (4a),
dihydrophenanthrenes (5a), dihydrophenanthrenes (6a), and
dihydrophenanthrenes (7a). Based on the above results, the
scavenging activity of loddigesiinols toward NO free radicals
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Table 4: Comparison of the DPPH, hydroxyl, and ABTS free radical scavenging abilities of polysaccharides from D. huoshanense, D.
chrysotoxum, and D. fimbriatum species.
Dendrobium species Chemical compounds DPPH concentration (mg/mL)
0.5% 1% 2% 3%
D. huoshanense and D. chrysotoxum Polysaccharides (scavenging effects %) 45–50 AB 80 90–95 —
D. fimbriatum Polysaccharides (scavenging effects %) — 10 — 40–50
Dendrobium species Chemical compounds Hydroxyl concentration (mg/mL)
0.5% 1% 2% 3%
D. huoshanense and D. chrysotoxum Polysaccharides (scavenging effects %) 50 60–65 80 —
D. fimbriatum Polysaccharides (scavenging effects %) — 55–60 — 70–75
Dendrobium species Chemical compounds ABTS concentration (mg/mL)
0.5% 1% 2% 3%
D. huoshanense and D. chrysotoxum Polysaccharides (scavenging effects %) AB 10 AB 20 AB 25 —
D. fimbriatum Polysaccharides (scavenging effects %) — AB 70 — AB 90
∗Notes: —: no tests and about: AB.
The scavenging hydroxyl free radicals abilities of polysaccharides fromD. huoshanense andD. chrysotoxum are stronger thanD. fimbriatum, and the scavenging
ABTS free radicals abilities of polysaccharides fromD. fimbriatum are stronger thanD. huoshanense andD. chrysotoxum polysaccharides. Results showed that
polysaccharides (scavenging DPPH effects %) fromD. huoshanense andD. chrysotoxum are higher than hydroxyl and ABTS. And polysaccharides (scavenging
ABTS effects %) from D. fimbriatum are higher than DPPH and hydroxyl free radicals.
is pronounced. The inhibitory actions of phenanthrenes and
dihydrophenanthrenes from D. loddigesii on the production
of NO and DPPH free radicals are recognised. The relevant
data and information are shown in Table 5 [71].
3.2. Anti-Inflammatory Activity
3.2.1. Inhibition of Nitric Oxide (NO) by D. nobile and D. chry-
santhum Constituents. It is known that, upon lipopolysac-
charide (LPS) stimulation, macrophages produce a large
amount of inflammatory factors, such as tumor necrosis fac-
tor𝛼 (TNF-𝛼), interleukin-1 beta (IL-1𝛽), interleukin 6 (IL-6),
interferon (IFN), and other cytokines. LPS induces endoge-
nous nitric oxide (NO) biosynthesis through induction of
inducible nitric oxide synthase (iNOS) in macrophages,
which is involved in inflammatory responses [42]. D. nobile
and D. chrysanthum constituents strongly inhibit TNF-𝛼, IL-
1𝛽, IL-6, and the NO production.
3.2.2. D. nobile Constituents. From D. nobile two new biben-
zyl derivatives, namely, nobilin D (given number 1) and
nobilin E (given number 2), and a new fluorenone, namely,
nobilone (given number 3), together with seven known
compounds (given numbers 4–10), including R
1
= R
2
=
OCH
3
R
3
= OH R
4
= H (4), R
1
= R
2
= R
3
= OCH
3
R
4
= H
(5), R
1
= R
2
= OH R
3
= R
4
= H (6), R
1
= R
3
= OCH
3
R
2
= OH R
4
= H (7), R
1
= OCH
3
R
2
= R
3
= OH R
4
= H (8),
R
1
= R
3
= OH R
2
= R
4
= H (9), and R
1
= R
3
= OH R
2
=
HR
4
= OCH
3
(10), have been identified. Compounds 1–3,
5, and 8–10 can inhibit NO production. On the other hand,
compounds 2 and 10 can exhibit a strong to resveratrol, while
enhanced cytotoxic potential has been found in compounds
4 and 7. Compounds 1–10 act as NO inhibitors, as evidenced
by oxygen radical absorbency capacity (ORAC) assays.These
findings are focused on all of these compounds, except
compound 6, and their inhibitory effects on NO production,
in murine macrophages (RAW 264.7), activated by LPS and
interferon (IFN-c¸) are shown in Table 5 [38]. Furthermore,
it was found that a new phenanthrene, together with nine
known phenanthrenes and three known bibenzyls, manifests
an inhibitory effect on NO production in RAW 264.7 cells.
The structures of all of the compounds (given numbers A–
M), including R
1
= R
3
= OH, R
2
= R
5
= OCH
3
, R
4
= H(A),
R
1
= R
4
= R
5
= OH, R
2
= H, R
3
= OCH
3
(B), R
1
= R
5
=
OH, R
2
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3
= OCH
3
, R
4
= H(C), R
1
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2
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3
, R
3
=
R
5
= OH, R
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= H R
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3
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1
= H,
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2
= OH, R
3
= OCH
3
(F), R
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= OCH
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, R
2
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= OH, R
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5
= H(G), R
1
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3
= OH, R
2
= OCH
3
(H), R
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= R
5
=
OH, R
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4
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3
= OCH
3
(I), R
1
= R
3
= OCH
3
, R
2
=
R
5
= OH, R
4
= H(J), R
1
= R
2
= R
4
= OH, R
3
= OCH
3
, R
5
=
H(K), R
1
= OCH
3
, R
2
= R
4
= H, R
3
= R
5
= OH(L), and
R
1
= R
2
= R
3
= OH, R
4
= R
5
= H(M), were elucidated by
analysis of the spectroscopic data, including extensive two-
dimensional nuclear magnetic resonance spectroscopy (2D-
NMR) and mass spectrometry (MS). All of compounds C, D,
I, K, and L are relatively strong inhibitors of NO production,
and their potencies are better than those of compoundsA and
E–H [58]. Compounds C, D, I, K, and L could inhibit NO
synthesis which might contribute to the suppression of LPS-
induced TNF-𝛼 and IL-1𝛽 production.
3.2.3. D. chrysanthum Constituents. Anti-inflammatory
compounds from ethyl acetate extracts of D. chrysanthum
species were evaluated. These structures were elucidated on
the basis of the high-resolution mass spectrometry, NMR
spectroscopy, and X-ray crystal diffraction analysis. A novel
phenanthrene phenol derivative with a spironolactone ring
(dendrochrysanene), namely, 2-hydro-7,70,100-trihydroxy-
4-40-dimethoxylspiro[(1H)-cyclopenta[a]naphthalene-3,30-
(20H)-phenanthro[2,1-b]furan]-1,20-dione, was identified.
Results showed anti-inflammatory activity of dendrochry-
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Table 5: Inhibition of compounds from D. loddigesii and D. nobile
species on NO and DPPH formation.
Species Chemical constituent NO DPPH
D.
loddigesii
Phenanthrenes (1a) 2.6 26.1
Phenanthrenes (2a) 6.4 59.8
Phenanthrenes (3a) 5.3 12
Phenanthrenes (4a) 10.9 —
Dihydrophenanthrenes (5a) 4.6 62.2
Dihydrophenanthrenes (6a) 29.1 —
Dihydrophenanthrenes (7a) 29.2 —
Loddigesiinols A 2.6 —
Loddigesiinols B 10.9 —
Loddigesiinols C — 23.7
Loddigesiinols D 69.7 —
D.
nobile
Nobilin D (1) 15.3 —
Nobilin E (2) 19.2 —
Nobilone F (3) 38.1 —
Phenanthrenes and bibenzyls
related-composition (4–10)
RO R1 = R2 = OCH3 R3 = OH R4 = H (4) — —
RO R1 = R2 = R3 = OCH3 R4 = H (5) 48.2 —
RO R1 = R2 = OH R3 = R4 = H (6) — —
RO R1 = R3 = OCH3 R2 = OH R4 = H (7) — —
RO R1 = OCH3 R2 = R3 = OH R4 = H (8) 36.8 —
RO R1 = R3 = OH R2 = R4 = H (9) 32.9 —
RO R1 = R3 = OH R2 = H R4 = OCH3 (10) 13.4 —
∗Notes: —: no tests; RO: relation composition.
Inhibitory effects of different compounds from D. loddigesii and D. nobile
species on NO production. Result shown in Table 5, ranked from high to
low as follows: loddigesiinol D > R1 = R2 = R3 = OCH3 R4 = H (5) >
nobilone F (3) > R1 = OCH3 R2 = R3 = OH R4 = H (8) > R1 = R3 = OH
R2 = R4 = H (9) > dihydrophenanthrenes (7a) > dihydrophenanthrenes
(6a) > nobilin E (2) > nobilin D (1) > R1 = R3 = OH R2 = H R4 =
OCH3 (10) > phenanthrenes (4a) = loddigesiinols B > phenanthrenes (2a) >
phenanthrenes (3a) > dihydrophenanthrenes (5a) > phenanthrenes (1a) >
loddigesiinols A, and all of the compounds inhibit DPPH prodruction
(from high to low): dihydrophenanthrenes (5a) > phenanthrenes (2a) >
phenanthrenes (1a) > loddigesiinol C > phenanthrenes (3a).
sanene on iNOS mRNA induced by LPS in mouse peritoneal
macrophages. Meanwhile, there are several inflammatory
cytokines, such as TNF-𝛼, IL-8, and IL-10, which were
inhibited. Thus, the beneficial effects of dendrochrysanene
compounds as anti-inflammatory agents were identified [72].
3.3. Sjo¨gren’s Syndrome (SS). Sjo¨gren’s syndrome (SS) is a
chronic autoimmune disease with disorder of the exocrine
glands. The symptoms are dry eyes, dry mouth, dry throat
and thirst with blurred vision, and so forth. The abnormal
distribution of salivary glands in SS leads to an inflam-
matory effect and pathological processes triggering lym-
phocyte infiltration and apoptosis. Lymphocyte infiltration
and apoptotic pathways, shown by regulation of Bax, Bcl-2,
and caspase-3, have been reported in submandibular glands
(SG). Furthermore, in pathological processes were also found
that the subsequent signal of cell expression to mRNA of
proinflammatory cytokines, such 30 as tumor necrosis (TNF-
a), interleukin (IL-1𝛽), and IL-6. As well as, a high level of
expression of aquaporin-5 (AQP-5) is identified.AQP-5 is one
of a water channel protein, and plays an important role in 31
the salivary secretions [73, 74].
Treatment with D. officinale polysaccharides (DP) could
suppress the progression of lymphocyte infiltration and apop-
tosis in SS and rectify the chaos of proinflammatory cytokines
including TNF-𝛼, IL-1 beta, and IL-6 in SG [71, 75] (Figure 1).
mRNA expression of TNF-𝛼 was inhibited. The process of
regulation resulted in a series of marked responses, such as
translocation of NF-𝜅B, prolonged MAPK, cytochrome C
release, and caspase-3 activation, which have been identified
[55, 76]. In addition to the findings onDP treatment, there are
reports on the findings on the extracts ofD. candidum andD.
nobile.
A clinical study found that, after 1 week of oral adminis-
tration of the extract of D. candidum, salivary secretion was
increased by approximately 65%. The extract promoted the
expression of aquaporin-5 useful for treatment of Sjo¨gren’s
syndrome (SS).
Chrysotoxine isolated from D. nobile can increase the
expression of AQP-5 in dry eyes, one of the symptoms of SS,
and restore the distribution of AQP-5 in lacrimal glands and
corneal epithelia, by inhibiting the release of cytokines, such
as IL-1, IL-6, and TNF-𝛼. In the meantime, it can activate the
mitogen-activated protein kinase (MAPK) signaling path-
ways. Furthermore, it elicits an increase in the production of
matrix metalloproteinase-9 (MMP-9). Ultimately, it leads to
an increase of saliva and tear secretion. The medical efficacy
of the extracts of D. officinale, D. nobile, and D. candidum
species has been demonstrated [43] (Figure 1).
3.4. Neuroprotective Effect (Parkinsonian Syndrome). Five
bioactive derivatives isolated from Dendrobium species,
namely, chrysotoxine (CTX), moscatilin, crepidatin, nobilin
B, and chrysotobibenzyl, are potential neuroprotective com-
pounds with antioxidant activity which can be used in
the treatment of Parkinson’s disease (PD). The IC
50
values
of DPPH free radical scavenging activities of chrysotoxine
(CTX), moscatilin, crepidatin, and nobilin B were 20.8 ± 0.9,
28.1 ± 7.1, 38.2 ± 3.5, and 22.2 ± 1.4, respectively. The above
data show that crepidatin is better than other compounds in
DPPH free radical scavenging capacity. CTX could selectively
antagonize MPP+ in dopaminergic pathways in the brain;
also 6-hydroxydopamine (6-OHDA) has been inhibited by
mitochondrial protection and NF-𝜅B modulation in SH-
SY5Y cells. Thus, it could explain how it may be beneficial
in preventing PD [44, 77].
In addition, results of CTX compound in Dendro-
bium nobile Lindl. used in treatment of PD have also
been clearly reported. We evaluated the pharmacokinetics
of oral (100mg/kg) and intravenous (25mg/kg) adminis-
tration of CTX preparation using high performance liq-
uid chromatography-tandem mass spectrometric (HPLC-
MS/MS)method in animal tests [78]. Results indicate efficacy
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Polysaccharide
HPS-IB23
OAc3 OAc2 OAc2 OAc3 OAc2
Cytokines factors
Hematopoietic growth factors
OAc3 𝛼-D-Gal 𝛼-D-Gal
[-Manp-(1-[---4)-𝛽-D---4)-b-D-Glcp-(1→4)-b-D-Manp-(1→4)-𝛽-D-Manp-(1→4)-𝛽-D-Manp-(1→4)-𝛽-D-Manp-(1→4)-𝛽-D-Manp-(1→4)-𝛽-D-Manp-(1→4-)-b-D-Manp-(1→4-]n
TNF-𝛼↑
GC-SF↑
GM-CSF↑
→1)-𝛼-D-Glup(6-1) -𝛼-D-Glup(6-1) -𝛼-D-Glup(6-1) -𝛼-D-Glup(6-1) -𝛼-D-Glup(6-1)-𝛼-D-Glup(6-1-𝛼-D-Glup(6→1) -𝛼-D-Glup(6-1) -𝛼-D-Glup(4-1) -𝛼-D-Glup(4-]n
∗Notes: inducement↓; activation↑
Figure 1: Cytokines activated by polysaccharide and polysaccharide (HPS-IB23) fromD. huoshanense.The effect of twoOAc3 and three Oac2
from polysaccharide on GC-SF and GM-CSF upregulation, and also the effect of one oAc3 and two 𝛼-D-Gal from polysaccharide (HPS-IB23)
on TNF-𝛼 upregulation.
and safety in treating PD conditions. The antioxidant mech-
anisms towards 6-OHDA and SH-SY5Y and regulation of
antiapoptosis in cell signaling pathways were described [52].
3.5. Immunomodulatory Activity. Lymphocytes can be clas-
sified as T lymphocytes, B lymphocytes, and macrophages,
respectively. They are important to immune cells and play
a key role for reactions and responses in the immune
system. Generally, there are various types of lymphocytes
which are activated by very complex signal transduction
pathways. Among all, the most common type is the action of
lipopolysaccharides (LPS) in macrophages, which are able to
produce many different kinds of proinflammatory cytokines,
especially TNF-𝛼, which is one of the main proinflammatory
cytokines and plays a critical role in mediating signal trans-
duction and stimulating the immune defense system [79].
The immunopotentiating action from Dendrobium species
produced by concanavalin A- (Con A-) stimulated prolifer-
ation of splenocytes in mouse. Finding the part of, which the
D. officinalis produced a more potent immunopotentiating
action, although it did not provided related to information
of biological activity [57].
Sesquiterpenes from D. nobile showed a comitogenic
effect on Con A- and LPS-stimulated mouse splenocytes.
Other chemical components, including polysaccharides
and sesquiterpene glycosides were also confirmed. Related
sesquiterpene glycosides with alloaromadendrane, emmotin,
and picrotoxane type aglycones, namely dendroside A, den-
dronobilosides A. In vitro biological tests suggest the types
of polysaccharides and sesquiterpene glycosides (given as
dendrosides D–G) significantly promoted cell proliferation
and more stimulation of mouse T and/or B lymphocytes
[45, 80]. On the other hand, compounds fromD.moniliforme,
namely, dendroside A, dendroside C, and vanilloloside, were
found to stimulate the proliferation of B cells and inhibit the
proliferation of T cells in vitro [46] (Table 6).
In addition, the leaf, stem (cell walls), and mucilage
isolated of D. huoshanense using chemical and enzymatic
analyzed by chromatographic and spectroscopic methods,
results demonstrated the bioactivity from polysaccharides
and it’s structure, HPS-1B23. The potential effects for main
composed ofmoremonosaccharides, showing Xyl, Ara,Man,
Glc, Gal, and GalA, by HPS-1B23, signify an increasing
immunostimulating activity through upregulating the levels
of several cytokines, including TNF-𝛼, IL-10, IL-6, and IL-
1 [47]. In addition, the stem cell mucilage polysaccharides
of D. huoshanense composed of 𝛽-(1-4)-D-Glcp and 𝛽-(1-4)-
D-Manp linkages with partial acetylated mannosides were
identified, which upregulated the growth factors GM-CSF
and G-CSF. DHP-4A stimulated RAW 264.7 macrophages
to secrete NO, TNF-𝛼, IL-6, and IL-10 by activating p38,
ERK, JNK, and NF-𝜅B. The results provide clear scientific
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Table 6: The chemical compounds from D. nobile and D. monili-
forme that inhibited/activated T cells and B cells.
Dendrobium
species Compound/structure
Lymphocytes
T cell B cell
D. nobile
Dendroside D (AD) (AD)
Dendroside E (AD) (AD)
Dendroside F (AD) (AD)
Dendroside G (AD) (AD)
D. moniliforme
Dendroside A (IY) (AD)
Dendroside C (IY) (AD)
Vanilloloside (IY) (AD)
Denbinobin (IY) (AD)
2,6-Dimethoxy 1,4,5,8-
phenanthradiquinone (IY) (AD)
∗Notes: activation: AD; inhibition: IY.
Up the table, showed T cell and B cell activated by chemical compounds from
D. nobile, and inhibit T cell and activated on B cell by chemical compounds
from D. moniliforme.
evidence on regulation of hematopoietic growth factors
and cytokines factors in the immune system by different
polysaccharides from D. huoshanense [81, 82]. Interestingly,
the total polysaccharides of D. huoshanense induced the
expression of interleukin-1 receptor antagonist (IL-1ra) in
human monocytes. Which the IL-1ra was regulated by 37
a series of signaling pathways, like ERK/ELK, p38 MAPK,
PI3K, and NF-𝜅B [83].
In addition, the water-soluble polysaccharides (DTP)
derived fromD. tosaensewere isolated by usingHPAEC-PAD,
HP-SEC, GC–MS, andNMR spectroscopy.They significantly
increased the number of natural killer (NK) cells, NK cyto-
toxicity,macrophage phagocytosis, and cytokine induction in
splenocytes, when administered orally to BALB/c mice for 3
weeks [59].
3.6. Treatment of Diabetes. The compounds isolated from
Dendrobium huoshanense (DHP) have been evaluated for
treatment of diabetes in recent years. The hypoglycemic
and antioxidative activities of three polysaccharides, namely,
D. officinale (DOP), D. nobile (DNP), and D. chrysotoxum
(DCP), have been compared in diabetic mice. Result showed
that the hypoglycemic effect of DHP was better than those
of DNP and DOP. In addition, the antioxidant effect of
DHP was better than those of DOP and DNP by regulating
the superoxide dismutase, catalase, malonaldehyde, and l-
glutathione levels in the liver and kidney. Thus, the hypo-
glycemic and antioxidant activities of DHPneed to be studied
more extensively in the future [60].
3.7. Antitumor Activity
3.7.1. The Anticancer Effect of D. chrysotoxum and D. nobile.
Fluorenone derivatives, namely, dendroflorin and den-
chrysan A, isolated from stems of D. chrysotoxum species,
show significant inhibitory effects on the growth of human
hepatomaBEL-7402 cells.The IC
50
values of 1,4,5-trihydroxy-
7-methoxy-9H-fluoren-9-one, denchrysan A 1, and den-
droflorin were 1.49 𝜇g/mL, 1.38 𝜇g/mL, and 0.97 𝜇g/mL,
respectively.
On the other hand, erianin, a phenanthrene from D.
chrysanthum, is recognized as an antitumor agent. Reports
showed that it has potent inhibitory activity in hepatoma
Bel7402, melanoma A375, and HL-60 cells, as evidenced
by inhibition of angiogenesis and induction of endothelial
cytoskeletal disorganization in vivo and in vitro, but did not
show antitumor activity [56, 61]. Thus, further investigation
is needed to identify if the antitumor mechanisms of erianin
and denbinobin are similar.
The antitumor effects of polysaccharides isolated from
stems of D. nobile, namely, DNP-W, DNP-OH, and DNP-
H, were studied. DNP-W was further fractionated to give
six subfractions including DNP-W1, DNP-W2, DNP-W3,
DNP-W4, DNP-W5, and DNP-W6 by using anion exchange
chromatography. The results show that DNP-W, DNP-OH
and DNP-H, DNP-W1, DNP-W2, and DNP-W3, especially
DNP-W1 and DNP-W3, have a strong antitumor action in
inhibiting sarcoma 180 in vivo and HL-60 cells in vitro [48].
In addition, denbinobin is a major phenanthrene isolated
from stems of D. nobile. The inhibitory mechanisms of
denbinobin in SNU-484 cells have been observed. It signifi-
cantly decreased the expressions of matrix metalloproteinase
(MMP-2) and (MMP-9) and induced apoptosis through
downregulation of Bcl-2 and upregulation of Bax in cancer
cells. These findings may be used to provide reference for
further studies on the pharmacological mechanisms from
denbinobin and polysaccharides in D. nobile [50, 51, 84].
3.7.2. Antilymphoma Activity of Dendrobium formosum.
Lymphoma is a cancer of the immune system. The ethanolic
extract of Dendrobium formosum showed antilymphoma
activity in vitro as evaluated by the MTT assay. It also
significantly prolonged survival time in Dalton’s lymphoma
bearing mice [85].
3.7.3. Anti-Lung-Cancer Activity of Dendrobium draconis.
The bibenzyl compound gigantol has been isolated from
Dendrobium draconis. It inhibits several cancer cell lines
and inhibits filopodia formation of the non-small-cell lung
cancer cells. The molecular mechanism of gigantol includes
(1) downregulating caveolin-1 (Cav-1), (2) activating ATP-
dependent tyrosine kinase, and (3) regulating cell division
cycle 42 (Cdc42) [86].
3.8. Antimicrobial Activity and Antifungal Activity. Dendro-
bium is an important economic plant; however, there have
been certain cultivation issues yet to be resolved, particularly
fungal infection [87]. Pythium vexans has been reported to
cause stem rot, crown rot, root rot, damping-off, and patch
canker in Dendrobium plants [88]. The diseases could lead
to damage to the seedlings of D. chrysotoxum, D. chrysan-
thum, D. thyrsiflorum, and D. aurantiacum, characterized
by water-soaked, brown or yellowish lesions with a brown
margin, resulting in dieback of the plants within a few days
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Table 7: The pharmacological effects of Dendrobium species.
Species Chemical compounds/structures Pharmacological activities References
D. nobile Polysaccharides Scavenging effect of hydroxyl, ABTS, and DPPH [40, 41]
(SR) Nobilin D, nobilin E, nobilone Inhibitory on NO production [42]
(SR) Phenanthrenes Inhibition of LPS-induced of nitric oxideproduction [38]
(SR) Dendroside A, Dendronobilosides A Immunomodulatory activity [43, 44]
(SR) Glycosides (dendrosides D–G) Significant Stimulation of the proliferation ofmouse T and/or B lymphocytes [43, 44]
(SR) Polysaccharides (DNP-W1, DNP-W2,DNP-W3, DNP-W4) Anticancer activity [45]
(SR) 4,7-Dihydroxy-2-methoxy-9,10-dihy Anticancer activity: [46]
Drophenanthrene, denbinobin (SNU-484 human gastric cancer cells) [46]
(SR) (SR) (human lung carcinoma), SK-OV-3 [47]
(SR) (SR) (human ovary adenocarcinoma) [47]
(SR) (SR) HL-60 (human promyelocytic leukemia) cell lines [47]
(SR) Bibenzyl Inhibit on furylfuramide [48]
(SR) (SR) 4-nitroquinoline-1-oxide (4NQO) [48]
(SR) (SR) N-Methyl-N󸀠-nitro-N-nitrosoguanidine [48]
(SR) (SR) UV irradiation [48]
(SR) (SR) 3-Amino-1,4-dimethyl-5H-pyrido[4,3b]indole(Trp-P-1) [48]
(SR) (SR) Benzo[a]pyrene (B[a]P) [48]
(SR) (SR) Aflatoxin B(1) [48]
(SR) Nobilin D Anti-inflammatory activity [42]
(SR) Nobilin E (SR) [42]
(SR) Nobilone (SR) [42]
(SR) R1 = R2 = OCH3 R3 = OH R4 = H (SR) [42]
(SR) R1 = R2 = R3 = OCH3 R4 = H (SR) [42]
(SR) R1 = R3 = OCH3 R2 = OH R4 = H (SR) [42]
(SR) R1 = OCH3 R2 = R3 = OH R4 = H (SR) [42]
(SR) R1 = R3 = OH R2 = R4 = H (SR) [42]
(SR) R1 = R3 = OH R2 = H R4 = OCH3 (SR) [42]
D. loddigesii Phenanthrenes Inhibition of nitric oxide (NO) [49]
(SR) Loddigesiinols A–D (SR) [49]
(SR) Moscatilin, moscatin, moscatilindiacetate
Inhibited both AA and collagen-induced platelet
aggregations [50, 51]
(SR) — Inhibition of aggregation of rabbit plateletsinduced by arachidonic acid and collagen [50, 51]
D. huoshanense Polysaccharides Inducing several cytokines, including IFN-c,IL-10, IL-6, and IL-1 [52]
(SR) (SR) Immunostimulating activity [52]
(SR) (SR) Increase of TNF-𝛼 production [52]
(SR) (SR) Inducing several cytokines, includinghematopoietic growth factors GM-CSF and GCSF [52]
D. denneanum Polysaccharides Scavenging effect of hydroxyl, ABTS, and DPPH [53]
D. fimbriatum Polysaccharides Scavenging effect of hydroxyl, ABTS, DPPH [54]
D. candidum Bibenzyl Antioxidant activity [20]
D. officinalis — Immunomodulatory activity [55]
D. findlayanum — Inhibition of Alternaria alternata and other [56]
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Table 7: Continued.
Species Chemical compounds/structures Pharmacological activities References
D. densiflorum Moscatilin, homoeriodictyol, scoparone,scopoletin, gigantol Antiplatelet aggregation activity [50, 51]
D. nobile, D.
chrysanthum Erianin
Anticancer activity: hepatoma Bel7402 melanoma
A375 and HL-60 cells [57]
D. chrysanthum, D.
huoshanense Dendrochrysanene
TNF-𝛼, IL-8, IL-10, and iNOS mRNAs were
induced readily from mouse peritoneal
macrophages by LPS
[58]
D. devonianum, D.
thyrsiflorum
Epicoccum sp., epicorazine A Epicorazine
B Inhibition of S. aureus, E. coli, and B. subtilis [59, 60]
D. devonianum, D.
thyrsiflorum Pyrenophorol derivatives
Inhibition of E.coli, Bacillus megaterium, and
Microbotryum violaceum [61]
∗Notes: —: no tests; SR: similar.
[89]. Interestingly, it also resulted in antimicrobial activity
from endophytic bacteria isolated from Dendrobium species.
Screening of various endophytic fungi from roots and stems
of different Dendrobium species, including 53 endophytic
fungi from D. devonianum; 23 endophytic fungi from D.
thyrsiflorum by way of morphological and/or molecular
biological methods, showed that 10 endophytic fungi from
D. devonianum and 11 endophytic fungi from D. thyrsiflorum
exhibited strong antimicrobial activity. Phoma, Epicoccum,
and Fusarium isolated from two abovementioned Den-
drobium species demonstrated antibacterial and antifungal
activities. The pyrenophorol derivatives of Phoma possessed
antagonistic activity against E. coli, Bacillus megaterium,
and Microbotryum violaceum, and Epicoccum sp. slightly
inhibited S. aureus, E. coli, and B. subtilis. Fusarium demon-
strated inhibitory effect on different pathogens. Moreover,
epicorazine A and epicorazine B derivatives of Epicoccum
nigrum isolated from D. thyrsiflorum possessed antibacterial
activity against S. aureus and B. subtilis and also inhibited the
growth of Gram-positive and Gram-negative bacteria, with a
potency stronger than that of ampicillin sodium [90–93].
3.9. Antimalarial and Antiherpetic Activities
3.9.1. Antimutagenic Activity. Moscatilin obtained from D.
nobile is a naturally occurring antimutagenic bibenzyl com-
pound. This compound can exert a suppressive effect on
the mutagenic activity of furylfuramide, 4-nitroquinoline-1-
oxide (4NQO), N-methyl-N󸀠-nitro-N-nitrosoguanidine, UV
irradiation, 3-amino-1,4-dimethyl-5H-pyrido[4, 3b]indole
(Trp-P-1), benzo[a]pyrene (B[a]P), and aflatoxin B(1) [94].
3.10. Diabetic Retinopathy (DR). Diabetes mellitus (DM) is
one of the metabolic diseases. It can cause many compli-
cations, such as kidney failure, stroke, and foot ulcers. The
ethanol extract of Dendrobium chrysotoxum (DC) used in
treatment of diabetic retinopathy reduced the expression
of a series of growing factors in DC-treated diabetic rats.
It decreased the retinal mRNA expression level of vascu-
lar endothelial growth factor (VEGF), vascular endothelial
growth factor receptor 2 (VEGFR2), serum growth factor
(SVEGF), matrix metalloproteinase (MMP) 2/9, basic fibrob-
last growth factor (bFGF), platelet-derived growth factor
(PDGF) A/B, insulin-like growth factor 1 (IGF-1), interleukin
1𝛽 (IL-1𝛽), interleukin 6 (IL-6), and phosphorylation of
p65. Moreover, a decrease in the expression of intercellular
adhesion molecule-1 (ICAM-1) has been reported [95].
3.11. Antiplatelet Aggregating Activity. Studies on the aggre-
gation of platelets induced through thrombin, arachidonic
acid (AA), thrombin, collagen, and platelet-activating factor
(PAF)were conducted by using 4 different aggregation induc-
ers. Animal tests disclosed that different Dendrobium species
including Dendrobium loddigesii and Dendrobium densiflo-
rum possess antiplatelet aggregating activity. The results
indicated some compounds isolated from two Dendrobium
species more effectively inhibited AA-induced aggregation
than they inhibited aggregation induced by PAF and collagen
[96]. In animal tests, the antiplatelet aggregation ofD. loddige-
sii species, which those compounds in part from moscatilin,
moscatin and diacetate. They inhibit platelet aggregation
was induced by AA was completely abolished by fraction 4
(50 𝜇g/mL) in rabbit platelets. Meanwhile, further demon-
strated there are strongly inhibited both AA and collagen-
induced platelet aggregations about 100𝜇g/mL. However, in
PAF there are no significant effects. In addition, comparison
of different compounds from D. densiflorum species, such
as moscatilin, homoeriodictyol, scoparone, scopoletin, and
gigantol, which the antiplatelet aggregation activity of their
were identified in vitro. Especially for scoparone has been
reported to possess potent antiplatelet aggregation whomore
than other compounds. Thus, it possible interactied by
compounds-compounds for antiplatelet aggregation [26, 97,
98] (Table 7).
4. Conclusion
In this paper, the history, chemistry, and pharmacology of
different Dendrobium species are reviewed. Especially for
biological pharmacology (Table 7). The pharmacological
activities examined include antioxidant, anti-inflammatory,
immunomodulatory, antitumor, antimicrobial/antifungal,
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antimutagenic activities, and antiplatelet aggregation acti-
vities. The ABTS, DPPH, and hydroxyl radical scavenging
effects of different polysaccharides such as DNP, DNP2-1,
DNP1-1, DNP3-1, and DNP4-2 have been investigated. Lod-
digesiinol, nobilone, dihydrophenanthrenes, and phenan-
threnes have been evaluated for nitric oxide (NO) scavenging
effect. Five types of polysaccharides from D. huoshanense, D.
chrysotoxum, and D. fimbriatum species were compared. D.
huoshanense and D. chrysotoxum polysaccharides exhibited
stronger DPPH and hydroxyl scavenging activity while D.
fimbriatum polysaccharides have stronger ABTS scavenging
activity. Dihydrophenanthrenes and loddigesiinol D were
isolated from D. loddigesii and D. nobile species. Dihy-
drophenanthrenes significantly inhibited DPPH production.
Loddigesiinol D significantly inhibited NO production.
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